Inogen’s third quarter earnings beat Wall Street expectations
Earnings, Health Care & Life Science, Latest news, Top Stories, Tri-County Public CompaniesInogen, a Goleta-based maker of direct-to-consumer respiratory products, beat analyst estimates for revenue when the company released third quarter earnings on Nov. 10. Revenues were up 38.7 percent from $29.4 million during the third quarter of last year to $40.8 million this year. Analysts had predicted revenues of $37 million. Inogen also reported adjusted Read More →
AppFolio reports strong revenue for third quarter
Latest news, Technology, Top StoriesAppFolio founder and chief strategist Klaus Schauser Santa Barbara-based cloud computing firm AppFolio said revenue jumped 56 percent to $20.3 million for the third quarter as losses grew to $4.8 million. The company, which specializes in providing business-to-business cloud services, said that it had increased both law firm and property management Read More →
FDA to review Amgen’s new kidney disease dug
East Ventura County, Health Care & Life Science, Latest newsThousand Oaks-based biotech giant Amgen announced on Nov. 6 that the Food and Drug Administration will review a new treatment for patients with chronic kidney disease. The new drug, Etelcalcetide, works by suppressing the secretion of a parathyroid hormone. The drug is administered intravenously three times per week at the end of a dialysis session. Read More →
Port Hueneme’s Stellar Biotechnologies trading on Nasdaq
Latest news, Technology, Tri-County Public Companies, West Ventura CountyPort Hueneme-based Stellar Biotechnologies started trading on the Nasdaq stock exchange Nov. 5. Stellar makes a protein for immunotherapy treatments using a unique sea snail only found off the coastal shores of a small part of California. Shares opened at $8.74 on Nov. 5 and were trading on the Nasdaq at $9.40 as of 11:30 Read More →
